These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30530252)

  • 1. #Drugsforsale: An exploration of the use of social media and encrypted messaging apps to supply and access drugs.
    Moyle L; Childs A; Coomber R; Barratt MJ
    Int J Drug Policy; 2019 Jan; 63():101-110. PubMed ID: 30530252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug dealing on Facebook, Snapchat and Instagram: A qualitative analysis of novel drug markets in the Nordic countries.
    Demant J; Bakken SA; Oksanen A; Gunnlaugsson H
    Drug Alcohol Rev; 2019 May; 38(4):377-385. PubMed ID: 31050051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Choice' of social media platform or encrypted messaging app to buy and sell illegal drugs.
    van der Sanden R; Wilkins C; Rychert M; Barratt MJ
    Int J Drug Policy; 2022 Oct; 108():103819. PubMed ID: 35961237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery dilemmas: How drug cryptomarket users identify and seek to reduce their risk of detection by law enforcement.
    Aldridge J; Askew R
    Int J Drug Policy; 2017 Mar; 41():101-109. PubMed ID: 28089207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safer scoring? Cryptomarkets, social supply and drug market violence.
    Barratt MJ; Ferris JA; Winstock AR
    Int J Drug Policy; 2016 Sep; 35():24-31. PubMed ID: 27241015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sellers' risk perceptions in public and private social media drug markets.
    Bakken SA; Demant JJ
    Int J Drug Policy; 2019 Nov; 73():255-262. PubMed ID: 31053409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Illicit drug prices and quantity discounts: A comparison between a cryptomarket, social media, and police data.
    Moeller K; Munksgaard R; Demant J
    Int J Drug Policy; 2021 May; 91():102969. PubMed ID: 33041184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing cryptomarkets for drugs. A characterisation of sellers and buyers over time.
    Tzanetakis M
    Int J Drug Policy; 2018 Jun; 56():176-186. PubMed ID: 29449105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Offline constraints in online drug marketplaces: An exploratory analysis of a cryptomarket trade network.
    Norbutas L
    Int J Drug Policy; 2018 Jun; 56():92-100. PubMed ID: 29621742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unsupervised machine learning approach for the detection and characterization of illicit drug-dealing comments and interactions on Instagram.
    Shah N; Li J; Mackey TK
    Subst Abus; 2022; 43(1):273-277. PubMed ID: 34214410
    [No Abstract]   [Full Text] [Related]  

  • 11. Will growth in cryptomarket drug buying increase the harms of illicit drugs?
    Aldridge J; Stevens A; Barratt MJ
    Addiction; 2018 May; 113(5):789-796. PubMed ID: 28766792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hidden wholesale: The drug diffusing capacity of online drug cryptomarkets.
    Aldridge J; Décary-Hétu D
    Int J Drug Policy; 2016 Sep; 35():7-15. PubMed ID: 27260863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reputation transferability across contexts: Maintaining cooperation among anonymous cryptomarket actors when moving between markets.
    Norbutas L; Ruiter S; Corten R
    Int J Drug Policy; 2020 Feb; 76():102635. PubMed ID: 31972474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transparency paradox. Building trust, resolving disputes and optimising logistics on conventional and online drugs markets.
    Tzanetakis M; Kamphausen G; Werse B; von Laufenberg R
    Int J Drug Policy; 2016 Sep; 35():58-68. PubMed ID: 26809972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forensic drug intelligence and the rise of cryptomarkets. Part II: Combination of data from the physical and virtual markets.
    Morelato M; Broséus J; De Grazia A; Tahtouh M; Esseiva P; Roux C
    Forensic Sci Int; 2018 Jul; 288():201-210. PubMed ID: 29763810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterising dark net marketplace purchasers in a sample of regular psychostimulant users.
    Van Buskirk J; Roxburgh A; Bruno R; Naicker S; Lenton S; Sutherland R; Whittaker E; Sindicich N; Matthews A; Butler K; Burns L
    Int J Drug Policy; 2016 Sep; 35():32-7. PubMed ID: 26872846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the relationship between online buyers and sellers of image and performance enhancing drugs (IPEDs): Quality issues, trust and self-regulation.
    van de Ven K; Koenraadt R
    Int J Drug Policy; 2017 Dec; 50():48-55. PubMed ID: 29028563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Associations Between Self-reported Tendencies Toward Smartphone Use Disorder and Objective Recordings of Smartphone, Instant Messaging, and Social Networking App Usage: Correlational Study.
    Marengo D; Sariyska R; Schmitt HS; Messner EM; Baumeister H; Brand M; Kannen C; Montag C
    J Med Internet Res; 2021 Sep; 23(9):e27093. PubMed ID: 34591025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Influences of the Darknet on Illicit Drug Diffusion.
    Bancroft A
    Curr Addict Rep; 2022; 9(4):671-676. PubMed ID: 36105116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'What if you live on top of a bakery and you like cakes?'-Drug use and harm trajectories before, during and after the emergence of Silk Road.
    Barratt MJ; Lenton S; Maddox A; Allen M
    Int J Drug Policy; 2016 Sep; 35():50-7. PubMed ID: 27157539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.